Similar Search Results

Cockburn, Iain M. - 1998

We examine the relationship between quality'' and market outcomes for a group of drugs used to treat rheumatoid arthritis. Though this is a widespread and debilitating disease with very substantial impacts on the health of patients and on the economy, currently available drugs have limited...

Persistent link: https://www.econbiz.de/10012472235

Immunization and Moral Hazard : The HPV Vaccine and Uptake of Cancer Screening

Moghtaderi, Ali - 2016

HPV vaccination for cervical cancer on participation in the Pap test, which is a diagnostic screening test to detect … HPV vaccine. A reduction in willingness to have a Pap test as a result of HPV vaccination would signal the need for public … health intervention. The HPV vaccination is recommended for women age eleven to twelve for regular vaccination or for women …

Persistent link: https://www.econbiz.de/10012456156

The Local Influence of Pioneer Investigators on Technology Adoption : Evidence from New Cancer Drugs

Agha, Leila - 2015

paper analyzes the influence of physician investigators who lead clinical trials for new cancer drugs. By comparing … diffusion patterns across 21 new cancer drugs, we separate correlated regional demand for new technology from information …

Persistent link: https://www.econbiz.de/10012457788

Pandemics, Vaccines and Corporate Earnings

Hong, Harrison - 2020

We estimate a model of damage to corporate earnings from COVID-19. An unexpected pandemic lowers current earnings due to costly mitigation and reduces growth rates. Damage depends on the expected arrival of a vaccine that reverts earnings to normal. Using this model, we infer from analysts'...

Persistent link: https://www.econbiz.de/10012481132

Price Indices and the Value of Innovation with Heterogenous Patients

Lucarelli, Claudio; Nicholson, Sean; Tilipman, Nicholas - National Bureau of Economic Research - 2021

- adjusted price indices for colorectal cancer drug treatments. We find that while the efficacy gains from newer drugs do not … justify high prices for the population as a whole, innovation improves the welfare of sicker, late-stage cancer patients. A …

Persistent link: https://www.econbiz.de/10012482551

Advances in Cost-Effectiveness Analysis of Health Interventions

Garber, Alan M. - 1999

The growing application of cost-effectiveness (CE) analysis and controversies about its methods has led to a need to explore its welfare economic foundations. Examination of its welfare theoretic foundations can provide a rationale for selecting specific standards for the application of CE...

Persistent link: https://www.econbiz.de/10012471590

Cost-Effective Policies to Reduce Vehicle Emissions

Fullerton, Don - 2005

This paper uses an estimated demand system that accounts for heterogeneity to calculate and compare the lost consumer surplus from a higher tax on gasoline, a tax on distance, or a subsidy for buying a newer car. We introduce a view of cost-effectiveness that compares policies instead of...

Persistent link: https://www.econbiz.de/10012467511

The Cost-Effectiveness of Alternative Instruments for Environmental Protection in a Second-Best Setting

Goulder, Lawrence H. - 1998

This paper uses analytical and numerical general equilibrium models to study the costs of achieving pollution reductions under a range of environmental policy instruments in a second-best setting with pre-existing factor taxes. We compare the costs and efficiency impacts of emissions taxes,...

Persistent link: https://www.econbiz.de/10012472341

Accounting for Future Costs in Medical Cost-Effectiveness Analysis

Meltzer, David - 1997

Most medical cost-effectiveness analyses include future costs only for related illnesses but this approach is controversial. This paper demonstrates that cost-effectiveness analysis is consistent with lifetime utility maximization only if it includes all future medical and non-medical...

Persistent link: https://www.econbiz.de/10012472878

Leakage, Welfare, and Cost-Effectiveness of Carbon Policy

Baylis, Kathy - 2013

We extend the model of Fullerton, Karney, and Baylis (2012 working paper) to explore cost-effectiveness of unilateral climate policy in the presence of leakage. We ignore the welfare gain from reducing greenhouse gas emissions and focus on the welfare cost of the emissions tax or permit scheme....

Persistent link: https://www.econbiz.de/10012459763

1
2
3
4
5
6
7
8
9
10
Next
Last